Diversa Limited (formerly Ambri Limited) has developed biosensor technology, drawing on work from the fields of biotechnology, nanotechnology, and electronics. Its primary technology is the Ion Channel Switch, a biosensing device. The Ion Channel Switch, or ICS, technology was developed using a membrane that acts as a switch, triggering an electrical current in the presence of particular molecules. Diversa plans to use the technology in point-of-care diagnostic products. The ICS was developed from research done by the Australian Membrane and Biotechnology Research Institute (AMBRI), the University of Sydney, and others. The company is headquartered in Queensland, Australia.

Street: 
Level 11, 66 Eagle Street
City: 
Brisbane
Postcode: 
4000
Federal State : 
Australia
WebSite: 
www.ambri.com
Fax: 
61-7-33038445

Company Index Score

Current Index Score Historical Index Score
  • Diversa Limited currently scores 50 % in the index.
  • Diversa Limited is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Diversa Limited is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets